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The epidermis is a stratified squamous epithelium com-
posed primarily of keratinocytes that undergo sequential
changes in gene expression during differentiation.
CCAAT/enhancer binding proteins (C/EBP) are mem-
bers of the bZIP family of DNA binding proteins/
transcription factors. Northern analysis demonstrated
that C/EBPa, C/EBPb, and C/EBPd mRNA are
expressed in mouse epidermis and their mRNA levels
were generally greater than those observed in other tissues
known to express high levels of C/EBP. Western analysis
of isolated epidermal cell nuclei demonstrated the pres-
ence of a 42 and 30 kDa C/EBPa protein and 35 kDa C/
EBPb protein. Immunohistochemical localization of C/
EBPa and C/EBPb in intact interfollicular epidermis
revealed that C/EBPb expression is exclusive to the nuclei
of a three-cell cluster of suprabasal keratinocytes that is
The epidermis is a stratified squamous epithelium com-posed primarily of keratinocytes that undergo a highlycoordinated program of sequential changes in geneexpression during differentiation from proliferating basalcells through morphologically distinct suprabasal cells,
ending in the nonviable cornified stratum corneum (Watt, 1989; Fuchs,
1990). The expression of catalytic proteins such as transglutaminase
(Thacher and Rice, 1985), assembly proteins such as filaggrin (Dale
et al, 1985), and structural proteins such as loricrin (Mehrel et al, 1990),
keratins (Fuchs and Green, 1980), involucrin (Simon and Green, 1984),
and cornifin-α/SPRR1 (Gibbs et al, 1993; Owens et al, 1996), is
strictly regulated as a function of the stage of keratinocyte differentiation.
The induction of certain differentiation responsive genes is tightly
coupled with the repression of others during differentiation. In addition
to undergoing a precisely defined program of differentiation, ker-
atinocytes are a rich source of numerous cytokines such as IL-1α, IL-
6, IL-7, IL-8, granulocyte macrophage-colony stimulating factor (GM-
CSF), and tumor necrosis factor-α that can regulate the function of
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morphologically consistent with the central column of
the epidermal proliferative unit, and that C/EBPa is
expressed in the nuclei and cytoplasm of suprabasal
keratinocytes and weakly expressed in a perinuclear man-
ner in some basal keratinocytes. In squamous cell carcin-
omas the expression of C/EBPa and C/EBPb was greatly
diminished as both the intensity of nuclear staining and
the number of cells expressing C/EBPa and C/EBPb
were reduced. In isolated primary mouse keratinocytes,
calcium-induced differentiation was accompanied by
specific temporal changes in the expression of C/EBPa,
C/EBPb, and C/EBPd mRNA and C/EBPa and C/
EBPb protein. These results implicate a role for the C/
EBP family in the regulation of genes involved in or
specifically expressed during the process of squamous
differentiation in epidermis. Key words: cytokines/skin/
transcription factors. J Invest Dermatol 110:939–945, 1998
cells in skin (for review, see Matsue et al, 1992). These epidermal
cytokines can act as autocrine and paracrine factors that may play a
role in amplifying responses of the skin to various stimuli such as
chemicals and UV light. Although cytokine expression in keratinocytes
and the coordinate and sequential alterations in specific genes involved
in keratinocyte differentiation have been well characterized, the tran-
scription factors that regulate these processes in keratinocytes are largely
uncharacterized.
CCAAT/enhancer binding protein α (C/EBPα) is a heat-stable
transcription factor that recognizes consensus sequence (59-
ATTGCGCAAT-39) within many promoters (Vinson et al, 1989;
Johnson, 1993). The C/EBP family contains at least seven members
that include C/EBPα, C/EBPβ (also termed NF-IL6, NF-M, IL-
6DBP, CRP2, or LAP), C/EBPδ (NF-IL6β or CRP3), C/EBPγ (Ig/
EBP-1), CRP1, d/CEBP, and CHOP10 (GADD153) (for review, see
Wedel and Loms Ziegler-Heitbrock, 1995). C/EBP proteins are
members of the bZIP family of DNA-binding proteins and consist of
three structural components: a C-terminal leucine zipper, a basic DNA-
binding region (Landschulz et al, 1988; Vinson et al, 1989), and an N-
terminal transactivating region (Friedman and McKnight, 1990). C/
EBP proteins share amino acid sequence similarities within their C-
terminal basic region/leucine zipper domain. The leucine zipper
domain is responsible for dimerization, whereas the basic region is
responsible for binding to specific DNA sequences (Vinson et al, 1989).
Both homo- and heterodimers of C/EBP isoforms can form and bind
to C/EBP sites within the promoters/enhancers of certain genes
(Friedman et al, 1989; Descombes et al, 1990; Cao et al, 1991; Williams
et al, 1991).
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The expression of C/EBP isoforms is most prominent in adipocytes,
hepatocytes, intestinal tissues, lung (Birkenmeier et al, 1989; Cao et al,
1991), monocytes/macrophage (Natsuka et al, 1992), and ovarian
follicles (Piontkewitz et al, 1993). C/EBPα is produced in tissues
capable of gluconeogenesis and lipogenesis, especially liver and fat
(Birkenmeier et al, 1989), and it is considered to play a direct role in
regulating transcription of some of the enzymes involved in controlling
these metabolic processes (McKnight et al, 1989). Many lines of
evidence indicate that C/EBPα plays a key role in the differentiation
of preadipocytes into adipocytes as it appears to function both by
inhibiting the clonal expansion that precedes adipocyte terminal differ-
entiation and by activating the coordinate expression of a group of
adipocyte genes whose promoters possess C/EBP-binding sites (Christy
et al, 1989; Cao et al, 1991; Umek et al, 1991; Freytag et al, 1994).
Recent studies indicate that C/EBPα inhibits cell proliferation of
fibrosarcoma cells through the upregulation of the cyclin-dependent
kinase inhibitor, p21 (Timchenko et al, 1996).
C/EBPβ plays a role at the early stages of preadipocyte differentiation
and leads to the expression of C/EBPα, after which C/EBPβ is
downregulated as the adipocytes acquire the complete fat-specific
phenotype (Cao et al, 1991; Yeh et al, 1995). C/EBPβ is more widely
expressed than C/EBPα, e.g., C/EBPβ expression increases during
differentiation of macrophage, myeloid, and plasma cells (Cooper et al,
1992; Natsuka et al, 1992; Scott et al, 1992), suggesting its involvement
in the differentiation of these lineages. Moreover, there is evidence
that C/EBPβ is involved in the regulation of the expression of several
cytokines and C/EBPβ binding motifs are found in the regulatory
regions of IL-1β, IL-6, IL-8, tumor necrosis factor-α, and granulocyte-
colony stimulating factor (G-CSF) (Akira et al, 1990; Mukaida et al,
1990; Drouet et al, 1991; Natsuka et al, 1992; Zhang and Rom, 1993).
Like C/EBPβ, C/EBPδ also appears to play a role at the early stages
of preadipocyte differentiation (Cao et al, 1991; Yeh et al, 1995).
Recent studies have demonstrated that C/EBPδ is important for
regulating the acute phase expression of the human C3 (the third
component of complement) gene in the presence of IL-1 (Juan et al,
1993), suggesting a role of C/EBPδ in the regulation of several IL-1
target genes.
As C/EBP proteins play a fundamental role in the differentiation of
preadipocytes to adipocytes and in the regulation of the expression of
many different genes encoding cytokines in several cell types, we
reasoned that C/EBP may be expressed in epidermis and they may
play an important role in differentiation and/or cytokine expression.
Our results demonstrate that C/EBPα, C/EBPβ, and C/EBPδ mRNA
are highly expressed in mouse epidermis and in primary keratinocytes.
Furthermore, C/EBPα and C/EBPβ proteins are preferentially
expressed in specific suprabasal keratinocytes in epidermis and their
expression is upregulated during calcium-induced differentiation of
primary keratinocytes.
MATERIALS AND METHODS
Materials Antibodies for C/EBP isoforms were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Keratin 1 polyclonal antibody was purchased
from Berkeley Antibody Company (Richmond, CA). Biotinylated secondary
goat anti-rabbit IgG was purchased from Boehringer Mannheim (Indianapolis,
IN). Peroxidase-conjugated streptavidin and 5,59-diaminobenzidine were pur-
chased from BioGenex (San Ramon, CA). Protease inhibitors, sodium orthovan-
adate, and DNAse were purchased from Sigma (St. Louis, MO). [α-32P]dCTP
was purchased from DuPont-New England Nuclear Research Products (Boston,
MA). Fetal bovine serum and trypsin were purchased from GIBCO BRL
(Gaithersburg, MD). EMEM (Ca11 free) was purchased from BioWhittaker
(Walkersville, MD). Epidermal growth factor was purchased from United States
Biochemical (Cleveland, OH).
Animals Female CD-1 mice, 6–7 wk old, or pregnant CD-1 mice were
purchased from Charles River Laboratories (Raleigh, NC). The mice were
kept in our facility for 1 wk prior to use and were fed rodent chow (Agway
Food, Granville Milling, Creedmore, NC) and water ad libitum. The mice were
kept on corn cob bedding and placed on a 12 h light/dark cycle until they
were used. The hair of the dorsal skin of 6–7 wk old mice was clipped with
electric clippers.
RNA isolation and northern blot analysis Epidermis was removed from
the dermis (Goodell et al, 1996) and total RNA was isolated from the epidermis/
other tissues or from primary mouse keratinocytes using the single-step
method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform
extraction as described previously (Chomczynski and Sacchi, 1987). Thirty
micrograms of each RNA sample was subjected to electrophoresis on a 1%
agarose-formaldehyde gel, transferred to a Zeta-probeGT nylon membrane (Bio-
Rad, Hercules, CA), and prehybridized at 65°C for 10 min in a solution
containing 0.25 M sodium phosphate buffer (pH 7.2) and 7% sodium dodesyl
sulfate. Hybridization was conducted overnight at 65°C with 25 ng of 32P-
labeled C/EBPα rat cDNA isolated from the pMSV-C/EBPα plasmid, a gift
from Dr. S. L. McKnight (University of Texas Southwestern Medical Center,
Dallas, TX). After hybridization, the membrane was washed and exposed to
Kodak X-OMAT AR film in a cassette with intensifying screens at –80°C.
The same membrane was stripped and reprobed with radiolabeled cornifin-α/
SPRR1 cDNA, a gift from Dr. A.M. Jetten (National Institute of Environmental
Health Sciences, Research Triangle Park, NC), 7S RNA cDNA, a gift from
Dr. A. Balmain (The Beatson Institute for Cancer Research, Glasgow, U.K.),
or polymerase chain reaction cloned mouse genes corresponding to C/EBPβ
and C/EBPδ. Mouse genomic DNA was utilized to polymerase chain reaction
clone the intronless C/EBPβ and C/EBPδ genes using the following forward
and reverse primer for C/EBPβ, 59-TTCTACTACGAGCCCGACTGCC-39
and 59-CAGCTTGTCCACCGTCTTCTTG-39, respectively, and the follow-
ing forward and reverse primers for C/EBPδ, 59-CCAGATTTTCATTT-
CGCTCCAG-39 and 59-TCGCAGGTCCCAAAGAAACTAG-39, respect-
ively. The identity of C/EBPβ and C/EBPδ polymerase chain reaction products
was confirmed by the size of the amplified product and restriction enzyme
analysis. 7S RNA cDNA was used to confirm that equal amounts of RNA
were loaded (Balmain et al, 1982). All cDNA were radiolabeled by random
priming using a random priming kit (GIBCO BRL) and [α-32P]dCTP (3000 Ci
per mmol, 10 µCi per µl) and purified from unincorporated [α-32P]dCTP
using Push Columns (Stratagene, La Jolla, CA).
Nuclei isolation from epidermal cells and western blot analysis The
preparation of epidermal cells from mouse skin was performed as described by
Goodell et al (1996). The epidermal cell nuclei were isolated as described by
Chapin et al (1994). The nuclei were resuspended in RIPA buffer [phosphate
buffered saline (PBS) containing 1% Nonidet P-40, 0.5% sodium deoxycholic
acid, and 0.1% sodium dodecyl sulfate] with protease inhibitors (100 µg
aprotinin per ml and 0.1 mM phenylmethylsulfonyl fluoride) and tyrosine
phosphatase inhibitor (1 mM sodium orthovanadate). The resuspension was
sonicated, incubated on ice for 1 h, and subjected to centrifugation for
20 min at 4°C, 11,000 3 g. In some experiments, epidermal cells or primary
keratinocytes were placed in the above buffer, sonicated, incubated on ice for
1 h, and subjected to centrifugation for 20 min at 4°C, 11,000 3 g. The
supernatant was stored at –80°C prior to analysis and the protein concentration
was determined using the Lowry method (Lowry et al, 1951). Epidermal
homogenate, C/EBPα and C/EBPβ standard proteins, and molecular weight
markers (GIBCO BRL) were boiled in sodium dodecyl sulfate sample loading
buffer for 4 min and subjected to reducing sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis through Tris-Glycine gels. The C/EBPα and C/
EBPβ standard proteins were gifts from Drs. Peter Johnson and Esta Sterneck
(National Cancer Institute, Bethesda, MD). The separated proteins were
electrophorectically transferred to an Immobilon P membrane (Millipore,
Bedford, MA). Following incubation in blocking buffer (PBS with 1% bovine
serum albumin, 5% milk, and 0.1% Tween) for 1 h at room temperature, the
membranes were probed overnight at 4°C with rabbit polyclonal IgG raised
against C/EBPα (1:5000), C/EBPβ (1:2500), keratin 1 AF109 (1:500), or
cornifin-α/SPRR1 (1:5000), a gift from Dr. A.M. Jetten (National Institute of
Environmental Health Sciences, Research Triangle Park, NC). The membranes
were then probed with a horseradish peroxidase-linked donkey anti-rabbit Ig
(Amersham, Arlington Heights, IL) for 1 h at room temperature. Detection
was made with a luminol system (ECL system, Amersham), and the resulting
light was then recorded on to Kodak BioMax MR film. Upon completion of
autoradiography, membranes were stained with amido black to confirm equal
protein content in all the lanes.
Immunohistochemical localization Skin samples (n 5 5), 7,12-dimethyl-
benz[a]anthracene-initiated/12-O-tetradecanoylphorbol-13-acetate-promoted
squamous papillomas (n 5 8), and squamous cell carcinomas (n 5 4) were
frozen in OCT compound (Miles, Elkhart, IN). Frozen sections (5 µm) on
Super Frost Plus slides (Fisher, Pittsburgh, PA) were air dried for 30 min at
room temperature and fixed in ice-cold acetone for 10 min on ice followed
by rinsing in three changes of PBS. The endogenous peroxidase activity was
quenched by incubation in 0.1% H2O2 in PBS for 10 min at room temperature.
After rinsing in three changes of PBS, the nonspecific binding of antibodies
was blocked by incubating the sections in 1% normal goat serum in PBS for
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Figure 1. C/EBPa, C/EBPb, and C/EBPd mRNA are abundantly
expressed in mouse epidermis. Total cellular RNA was isolated from the
epidermis and several other tissues and northern blot analysis was conducted.
C/EBPα, C/EBPβ, and C/EBPδ mRNA sizes were 2.7, 2.0, and 1.8 kb,
respectively. The membrane was reprobed with 7S RNA cDNA to verify the
equal loading of RNA.
30 min at room temperature. The excessive blocking solution was drained and
the sections were then incubated with the primary polyclonal antibodies against
C/EBPα (1:25,000) and C/EBPβ (1:10,000) in 1% bovine serum albumin in
PBS at 4°C overnight. After washing with PBS, the samples were incubated
with a biotinylated goat-anti-rabbit IgG for 30 min at room temperature
followed by a 30 min incubation with peroxidase conjugated streptavidin. The
avidin/biotin-peroxidase complexes were visualized by incubation with 5,59-
diaminobenzidine (following the manufacturer’s protocol). The sections were
counterstained lightly with Harris-modified hematoxylin, dehydrated, and
permounted with cover glasses. No C/EBP isoform staining was observed
when the primary antibody was omitted and the control rabbit serum was applied.
Isolation and culture of primary keratinocytes Primary keratinocytes
were isolated from newborn CD-1 mice (1–2 d old) by trypsin floatation
(Hennings et al, 1980). Isolated epidermal cells were plated at 6 3 106 cells per
60 mm plate in Ca11 free EMEM supplemented with 10% fetal bovine serum
and 4 ng epidermal growth factor per ml for 4 h to enhance keratinocyte
attachment. Cells were then gently washed with Mg11 and Ca11 free PBS
twice to remove any remaining calcium and then cultured in Ca11 free EMEM
supplemented with 8% chelex-treated fetal bovine serum and 4 ng epidermal
growth factor per ml. Calcium chloride was then added to produce a final
concentration of 0.05 mM Ca11. After 3 d in culture, calcium chloride was
added to produce a final concentration 0.12 mM Ca11 or 1.5 mM Ca11
(Yuspa et al, 1989). At various times, keratinocytes were harvested for the
isolation of protein and RNA for western and northern analysis, respectively.
RESULTS
C/EBPα, C/EBPβ, and C/EBPδ are abundantly expressed in
mouse epidermis In order to determine whether C/EBPα, C/
EBPβ, and C/EBPδ mRNA are expressed in mouse epidermis, total
RNA was isolated from the epidermis and northern blot analysis
was conducted. For comparison purposes, northern analysis was also
conducted on total RNA isolated from several other organs or tissues
known to express specific isoforms of C/EBP (Birkenmeier et al, 1989;
Cao et al, 1991; Williams et al, 1991). As shown in Fig 1, C/EBPα,
C/EBPβ, and C/EBPδ mRNA are expressed in the epidermis with
an approximate size of 2.7, 2.0, and 1.8 kb, respectively. Close
inspection revealed two bands (µ2.7–3.0 kb) that hybridized with the
C/EBPα cDNA, as the lower band more closely approximates the
size of C/EBPα transcripts in other tissues we only made comparisons
to this band. When C/EBPα mRNA levels in epidermis were
compared with mRNA levels in liver, lung, and fat, three tissues
known to express high levels of C/EBPα, epidermal C/EBPα mRNA
levels were higher than liver and lung and similar to that observed in
fat. When the levels of C/EBPβ and C/EBPδ mRNA were compared
with mRNA levels of C/EBPβ and C/EBPδ in other tissues known
to express high levels of these isoforms, the mRNA levels of C/EBPβ
and C/EBPδ were expressed at their highest level in the epidermis.
Figure 2. Expression of C/EBPa and C/EBPb proteins in the mouse
epidermis. Epidermal cells were isolated from mouse skin by trypsinization.
Whole homogenate or nuclei extract was prepared and western blot analysis
was conducted using isoform specific rabbit polyclonal antibodies made to rat
C/EBPα amino acids 253–265 and rat C/EBPβ amino acids 258–276. (A)
Lane 1, C/EBPα standard protein; lane 2, epidermal nuclei extract, 20 µg;
lane 3, epidermal homogenate, 40 µg. (B) Lane 1, C/EBPβ standard protein;
lane 2, epidermal nuclei extract, 20 µg.
To assure that C/EBPα, C/EBPβ, and C/EBPδ are expressed at
the protein level, epidermal cells were isolated from mouse skin by
trypsinization, nuclei were isolated, and western blot analysis was
conducted using isoform specific antibodies. As shown in Fig 2(A),
the C/EBPα specific antibody recognized a 42 and 30 kDa protein in
the epidermal nuclei preparation (lane 2) as well as in the epidermal
homogenate (lane 3). Based on the molecular weight of these proteins
and the known molecular weights of C/EBPα (Wedel and Loms
Ziegler-Heitbrock, 1995), as well as the mobility of the C/EBPα
standard (histidine-tagged bacterially expressed protein runs slightly
slower), we have classified these proteins as C/EBPα p42 and C/
EBPα p30. In addition, C/EBPα p42 was detected as a doublet,
suggesting the possibility of post-translational modification of C/EBPα
protein by phosphorylation. Minor bands are not visible when exposure
times are decreased. As shown in Fig 2(B), a 35 kDa protein was
detected in the epidermal nuclei preparation by the C/EBPβ specific
antibody. This protein comigrated with the C/EBPβ standard (histid-
ine-tagged bacterially expressed protein runs slightly slower), and we
have classified this 35 kDa protein as C/EBPβ. The identity of the
higher molecular weight band (42 kDa) is unknown; however, it likely
represents binding of the primary antibody as incubation with the
secondary antibody alone did not produce this band. In addition, this
42 kDa protein is present in C/EBPβ knockout mouse epidermis
(Sterneck et al, 1997), although the 35 kDa C/EBPβ protein is absent
(data not shown). These results indicate that the 42 kDa protein is not
related to the expression of C/EBPβ. Finally, we were not able to
detect C/EBPδ protein with a commercial C/EBPδ specific antibody.
As other antibodies to C/EBPδ are not available, we do not know if
the C/EBPδ protein is not expressed or if the antibody we utilized
failed to recognize C/EBPδ protein.
C/EBPα and C/EBPβ each display a unique cellular and
subcellular distribution within specific keratinocytes in intact
epidermis, and their expression is altered in skin neoplasms In
order to determine which cells of the epidermis express C/EBPα and
C/EBPβ, immunohistochemical localization was conducted on intact
frozen skin sections. As shown in Fig 3(A), C/EBPα was expressed
in the nuclei and cytoplasm of suprabasal keratinocytes and was weakly
expressed in a perinuclear manner in some basal keratinocytes. No
detectable C/EBPα staining was observed in the stratum corneum.
Also, we have conducted competition experiments in which we
preincubated the C/EBPα antibody with bacterially expressed
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Figure 3. C/EBPa and C/EBPb display
a unique cellular and subcellular distribu-
tion within specific keratinocytes in
intact epidermis and are altered in skin
neoplasms. The intact sections of control
and 12-O-tetradecanoylphorbol-13-acetate
treated (5 nmol, 2X) skins and neoplasms
were stained for C/EBPα and C/EBPβ as
described in Materials and Methods. (A) C/
EBPα in normal epidermis; (B) C/EBPα in
normal epidermis (higher magnification); (C)
C/EBPα in TPA treated epidermis; (D) C/
EBPα in squamous papilloma; (E) C/EBPα
in squamous cell carcinoma; (F) C/EBPβ in
normal epidermis; (G) C/EBPβ in normal
epidermis (higher magnification); (H) C/
EBPβ in TPA treated epidermis; (I) C/EBPβ
in squamous papilloma; (J) C/EBPβ in
squamous cell carcinoma. No C/EBP isoform
staining was observed when the primary
antibody was omitted or when the control
rabbit serum was applied. The arrowheads
indicate the nuclei expression of C/EBPβ in
three-cell clusters at each EPU in normal
epidermis. ep, epidermis; d, dermis. Scale bars,
10 µm.
C/EBPα protein or the C/EBPα peptide used to make the antibody,
and then carried out immunohistochemical staining of the epidermis.
When the C/EBPα antibody was preincubated with the bacterially
expressed C/EBPα protein or the C/EBPα peptide, it did not produce
any staining in the epidermis, whereas the control antibody not
preincubated with the bacterially expressed C/EBPα protein or the
C/EBPα peptide produced the characteristic C/EBPα staining pattern
(data not shown). Figure 3(B) shows higher magnification of C/EBPα
staining in the epidermis. Next, we examined C/EBPα expression in
hyperplastic epidermis in an attempt to better localize its expression as
well as to examine its expression under conditions of non-neoplastic
cell growth. As shown in Fig 3(C), in hyperplastic epidermis C/EBPα
was localized to the nuclei of spinous and granular keratinocytes with
no detectable staining in the stratum corneum and little to no staining
in basal keratinocytes. In squamous papillomas the expression of C/
EBPα was similar to that observed in hyperplastic epidermis (Fig 3D);
however, in squamous cell carcinomas C/EBPα expression was greatly
diminished as both the intensity of nuclear staining and the number
of cells expressing C/EBPα were reduced (Fig 3E). In addition, the
specific pattern of expression observed in the epidermis and squamous
papillomas was absent and the cells expressing C/EBPα appeared
randomly distributed.
C/EBPβ expression demonstrated a highly ordered and specific
pattern in the epidermis. C/EBPβ expression was exclusive to the
nuclei of a three-cell cluster of suprabasal keratinocytes and these
intensely stained clusters were repeated at regular intervals throughout
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Figure 4. C/EBPa, C/EBPb, and C/EBPd mRNA are altered in primary
keratinocytes induced to differentiate by increasing extracellular
calcium concentration. Mouse keratinocytes were isolated as described in
the Materials and Methods. Keratinocytes were plated in media containing
0.05 mM Ca11 cultured for 3 d and switched to media containing 0.12 mM
Ca11. Keratinocytes were harvested at the indicated times (in hours) after the
calcium switch and RNA was extracted and northern analysis conducted. F,
floating cells that were collected on day 2 after the initial plating. Although 7S
RNA is increasing with time, densitometric scanning of the photographic
negative of the ethidium bromide stained 18S or 28S RNA before RNA was
transferred to membrane did demonstrate equal loading.
the epidermis (Fig 3F). This characteristic pattern is morphologically
consistent with the central suprabasal column of the epidermal prolifer-
ative unit (EPU) (Potten, 1974; Morris et al, 1985). No detectable
C/EBPβ staining was observed in the stratum corneum. When
immunohistochemical staining experiments were conducted on the C/
EBPβ knockout mouse skin using the above C/EBPβ antibody, we
found no immunohistochemical staining in the skin (data not shown).
Figure 3(G) shows higher magnification of C/EBPβ staining of the
three-cell cluster of suprabasal keratinocytes. In hyperplastic epidermis
the highly ordered expression pattern of C/EBPβ observed in normal
epidermis was absent; however, C/EBPβ was expressed in the nuclei
of the suprabasal keratinocytes with no detectable expression in basal
keratinocytes (Fig 3H). In squamous papillomas the expression of C/
EBPβ was similar to that observed in hyperplastic epidermis (Fig 3I);
however, in squamous cell carcinomas C/EBPβ expression was greatly
diminished (both staining intensity and number of cells) and there was
a loss of the expression patterns observed in squamous papillomas or
epidermis (Fig 3J).
C/EBPa and C/EBPb expression is increased in primary mouse
keratinocytes induced to differentiate by high extracellular
calcium concentrations Basal mouse primary keratinocytes can be
cultured in medium containing 0.05 mM Ca11; however, the terminal
differentiation can be induced by increasing the level of extracellular
calcium in the media (Hennings et al, 1980). We wanted to determine
whether calcium-induced differentiation of primary mouse ker-
atinocytes is associated with alterations in the temporal expression of
C/EBP isoforms. We chose to examine the effect of two extracellular
calcium concentrations (0.12 mM and 1.5 mM Ca11) on the expression
of C/EBP isoforms as the expression of certain differentiation markers
in mouse keratinocytes is coupled to the level of extracellular calcium
concentrations (Yuspa et al, 1989). Primary mouse keratinocytes were
cultured in medium containing 0.05 mM Ca11 for 3 d and then
switched to either 0.12 mM or 1.5 mM Ca11. The switch to 0.12
and 1.5 mM Ca11 was associated with changes in keratinocyte
morphology, characteristic of a more differentiated phenotype (Hen-
nings et al, 1980), that were apparent at 8 and 1.5 h, respectively. As
shown in Fig 4, the switch to 0.12 mM Ca11 was accompanied by
Figure 5. C/EBPa and C/EBPb proteins are altered in primary
keratinocytes induced to differentiate by increasing extracellular
calcium concentration. Mouse keratinocytes were isolated as described in
the Materials and Methods. Keratinocytes were plated in media containing
0.05 mM Ca11 cultured for 3 d and switched to media containing 0.12 mM
Ca11. Keratinocytes were harvested at the indicated times (in hours) after the
calcium switch and proteins were analyzed by western analysis. F, floating cells
that were collected on day 2 after the initial plating.
changes in the expression of C/EBPα, C/EBPβ, C/EBPδ, and cornifin-
α/SPRR1 mRNA. C/EBPα mRNA was maximally increased at 8
and 16 h, followed by a decrease at 40 h. C/EBPβ mRNA levels were
only slightly increased at all time points after the switch to 0.12 mM
Ca11, whereas C/EBPδ levels were decreased at all time points after
the switch. Cornifin-α/SPRR1 mRNA was maximally increased at
16 and 40 h after the switch to 0.12 mM Ca11. Floating cells,
presumably differentiated keratinocytes, were collected on days 1 and
2 after the initial plating, as shown in Fig 4, northern analysis of
floating cells collected on day two demonstrated high levels of C/
EBPα, C/EBPβ, and cornifin-α/SPRR1 mRNA expression. Western
analysis demonstrated modest increases in C/EBPα protein at 16 and
40 h of 20% as determined by lasar densitometric scanning of exposed
film, whereas C/EBPβ protein was increased 2-fold by 1.5 h and 7–
8-fold at 16 and 40 h (Fig 5). Both keratin 1 and cornifin-α/SPRR1
protein could be detected at 16 and 40 h and both were expressed at
high levels in the floating cells. Keratinocytes that were not switched
to high calcium containing medium, but that continued to be cultured
in 0.05 mM Ca11, did not demonstrate changes in C/EBPα, C/
EBPβ, cornifin-α/SPRR1, and K1 from the levels observed at time
zero (data not shown).
Western analysis of proteins isolated from keratinocytes switched to
1.5 mM Ca11 medium were similar to the results obtained with
0.12 mM Ca11, with the exception that C/EBPα protein remained
at control levels until 4 h and then decreased at 8 and 16 h and was
barely detectable at 40 h, and that C/EBPβ and cornifin-α/SPRR1
levels were increased at one time point earlier than that observed in
0.12 mM Ca11 medium and keratin 1 protein could not be detected
(data not shown).
DISCUSSION
The results presented in this paper demonstrate that the bZIP transcrip-
tion factors C/EBPα, C/EBPβ, and C/EBPδ are abundantly expressed
at the mRNA level in mouse epidermis and C/EBPα and C/EBPβ
are expressed in specific subpopulations of suprabasal keratinocytes in
intact epidermis. It has been proposed that the epidermis is organized
into units, referred to as the EPU (Potten, 1974). Our finding that C/
EBPβ expression is exclusive to the nuclei of a three-cell cluster of
suprabasal keratinocytes, and that these intensely stained clusters are
repeated at regular intervals throughout the epidermis, suggests that
these cells are morphologically consistent with the differentiative
column of the EPU (Potten, 1974; Morris et al, 1991). The EPU is
composed of a suprabasal column or a stack of three nucleated cells
that exhibit a flat hexagonal morphology that covers an area of µ10
basal cells below it. Within this hexagonal area of 10 basal keratinocytes,
a centrally located keratinocyte has been identified that is a slow cycling
cell and is considered to have an unlimited capacity for self-renewal,
whereas the remaining basal cells of the EPU are either transient
amplifying cells with a limited capacity for self-renewal or post-mitotic
daughter cells that have no proliferative capacity (Potten, 1974). Within
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the EPU, differentiation is strictly coordinated with proliferation and
involves the movement of a post-mitotic basal keratinocyte to the
suprabasal layer, this process eventually results in a column or stack of
three post-mitotic suprabasal keratinocytes in various stages of terminal
differentiation. The highly specific and ordered expression of C/EBPβ
suggests that C/EBPβ plays an integral role within the cells of the
EPU. Another bZIP protein, c-Fos, which has been proposed to
function in the terminal stages of epidermal differentiation, also exhibits
exclusive expression in the three cells of the EPU (Fisher et al, 1991).
Fos and C/EBP can form heterodimers in vitro (Hsu et al, 1994)
that could impart another level of specificity to the regulation of
differentiation responsive genes.
It is intriguing that the highly ordered specific expression of
C/EBPβ is absent in phorbol ester-induced hyperplastic epidermis,
papillomas, and squamous cell carcinomas, indicating that the deregu-
lated keratinocyte growth is accompanied by loss of the ordered C/
EBPβ-EPU structure. This concept is supported by Morris et al (1985),
who provided evidence that phorbol ester causes the premature vertical
migration of basal keratinocytes located at the periphery of the EPU
and the proliferation of the centrally located slow cycling cell of EPU.
The consequence of the loss of C/EBPα and C/EBPβ expression in
the squamous cell carcinomas is not understood; however, it is known
that keratin 1, keratin 10, loricrin, and filaggrin are absent or greatly
reduced in squamous cell carcinomas (Yuspa et al, 1991). C/EBP
binding sites are found in the promoter regions of keratin 1, keratin
10, and involucrin. Further study will be required to determine if
there is any relationship between the alteration in the expression of
these genes in squamous cell carcinomas and loss of C/EBPα and C/
EBPβ expression.
The vast majority of C/EBPα present in the epidermis is in the
nuclei and cytoplasm of suprabasal cells, and we conclude that these
cells represent suprabasal keratinocytes based on the fact that the
keratinocyte is the predominate cell type in the epidermis (µ95%) and
C/EBPα is expressed in primary mouse keratinocytes. In addition,
recent reports have demonstrated that C/EBPα and C/EBPβ are
expressed in cultured human foreskin (Wang et al, 1996) and that C/
EBPα is expressed in adult keratinocytes and in suprabasal cells of
human epidermis (Swart et al, 1997). At this time we do not know
the identity of the few basal cells that express C/EBPα; however,
these cells may represent post-mitotic keratinocytes committed to
differentiation and to the eventual upward movement to the suprabasal
layers, or a minor epidermal cell type such as Langerhans cells or
melanocytes. The fact that C/EBPα is expressed in isolated ker-
atinocytes cultured in 0.05 mM Ca11 medium suggests that it has a
function in basal keratinocytes.
Our finding that calcium-induced differentiation of primary ker-
atinocytes is associated with increases in C/EBPα and C/EBPβ protein,
provides further evidence for a role for C/EBP isoforms in the
regulation of genes that are specifically expressed during squamous
differentiation or genes involved in the process of differentiation. It is
clear that C/EBPβ is highly induced in medium containing 0.12 mM
Ca11, whereas C/EBPα is modestly induced. As C/EBP isoforms can
form homodimers as well as heterodimers it is possible that the large
increase in C/EBPβ allows for heterodimerization with C/EBPα,
which in itself has a different regulatory function than either C/EBPα
or C/EBPβ homodimers. The heterodimerization between different
C/EBP isoforms, as well as interactions between C/EBP isoforms and
other transcription factors such as AP-1 (Jun/Fos) (Hsu et al, 1994)
and NF-κB (Stein et al, 1993), could provide an additional level of
complexity in determining the functional properties of this group of
transcription factors. Our observations that different levels of high
calcium (0.12 vs 1.5 mM Ca11) have different effects on the temporal
expression and level of expression of C/EBPα, C/EBPβ, keratin 1,
and cornifin-α/SPRR1, is consistent with the results of Yuspa et al
(1989) who demonstrated that the expression of certain differentiation
markers in mouse keratinocytes is coupled to the level of extracellular
calcium concentrations. For example, Yuspa et al (1989) demonstrated
that spinous and granular markers are expressed in mouse keratinocytes
in media containing 0.12 mM Ca11, but higher levels of Ca11 such
as those ù 1 mM cause a rapid differentiation in which granular
markers are rapidly expressed but spinous markers such as keratin 1
are not expressed. Differences in C/EBP isoform expression in media
containing 0.05, 0.12, and 1.5 mM Ca11 indicate that the expression
of these proteins is altered by different levels of calcium, and as such
their expression may be related to the calcium gradient found in intact
epidermis.
It is apparent that the levels of C/EBPα and C/EBPβ mRNA do
not always coincide with the levels of their encoded proteins, which
suggests that C/EBP protein expression is also controlled at post-
transcriptional and/or translational levels. This is most evident in the
floating cells where high levels of C/EBPα and C/EBPβ mRNA are
present; however, protein levels are not correspondingly elevated. The
discrepancy between mRNA levels and protein levels of C/EBP
isoforms has been observed in other cell types and tissues (Birkenmeier
et al, 1989; Descombes et al, 1990; Williams et al, 1991) and further
supports the hypothesis that the expression of C/EBP proteins are
regulated at post-transcriptional and/or translational levels. Finally, in
primary keratinocytes we found only one C/EBPα message and only
the C/EBPα p42 kDa protein, whereas in epidermal preparations from
intact epidermis we found two C/EBPα messages as well as C/EBPα
p42 and C/EBPα p30 proteins. Whether the second mRNA species
and the 30 kDa protein are related is not known.
Keratinocytes express numerous cytokines such as IL-1α, IL-6, IL-
7, IL-8, GM-CSF, and tumor necrosis factor-α (for review, see Matsue
et al, 1992). Epidermal keratinocytes are a vast reservoir of IL-1
(Schmitt et al, 1986) and higher levels of IL-1α protein are associated
with suprabasal keratinocytes rather than with the basal keratinocytes
in mouse epidermis (Lee et al, 1994). In addition to IL-1α, it has been
shown that GM-CSF protein is localized to suprabasal keratinocytes
within the epidermis (Robertson et al, 1994). C/EBPβ is involved in
the regulation of the expression of several cytokines (Akira et al, 1990;
Mukaida et al, 1990; Drouet et al, 1991; Natsuka et al, 1992; Zhang
and Rom, 1993). Therefore, it is possible that C/EBP proteins may
be involved in the regulation of the expression of cytokines within
suprabasal keratinocytes, because C/EBPα and C/EBPβ and certain
cytokines are predominately expressed in these cells.
Although further studies are required to elucidate the genes that C/
EBP isoforms regulate in keratinocytes, our study provides new insights
and novel information regarding C/EBP isoform expression in specific
suprabasal keratinocytes of intact epidermis, as well as their expression
in primary keratinocytes induced to terminally differentiate by elevated
levels of extracellular calcium. Collectively, our results suggest a role
for C/EBP isoforms in the regulation of genes involved in or specifically
expressed during the process of squamous differentiation in epidermis.
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